MicroRNAs in myocardial ischemia: Identifying new targets and tools for treating heart disease. New frontiers for miR-medicine

Cellular and Molecular Life Sciences

Volumn 71, Issue 8, 2014, Pages 1439-1452

  Sala, V ^a   Bergerone, S ^b   Gatti, S ^a   Gallo, S ^a   Ponzetto, A ^a   Ponzetto, C ^a   Crepaldi, T ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^c Institute of Anatomy   (Italy)

Author keywords

Heart failure; miRNAs; Myocardial ischemia; myomiRs

Indexed keywords

ANTAGOMIR; BIOLOGICAL MARKER; MICRORNA; MICRORNA 1; MICRORNA 101; MICRORNA 126; MICRORNA 133; MICRORNA 145; MICRORNA 15; MICRORNA 199; MICRORNA 21; MICRORNA 210; MICRORNA 214; MICRORNA 221; MICRORNA 24; MICRORNA 29; MICRORNA 30; MICRORNA 320; MICRORNA 34; MICRORNA 378; MICRORNA 494; MICRORNA 499; MICRORNA 590; MICRORNA 711; MICRORNA 92; UNCLASSIFIED DRUG;

APOPTOSIS; CARDIAC PROGENITOR CELL; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; ENDOTHELIUM CELL; FEEDBACK SYSTEM; FIBROBLAST; GENETIC REGULATION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; MOLECULAR PATHOLOGY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; REGENERATIVE MEDICINE; REVIEW; STEM CELL;

APOPTOSIS; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; GENETIC THERAPY; HUMANS; MICRORNAS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; NECROSIS; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATIVE MEDICINE;

EID: 84897116690     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1504-0     Document Type: Review

References (164)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al (2012) Heart disease and stroke statistics-2012 update a report from the American Heart Association. Circulation 125:E2-E220
2. Buja LM, Weerasinghe P (2010) Unresolved issues in myocardial reperfusion injury. Cardiovasc Pathol 19:29-35
3. de Groot H, Rauen U (2007) Ischemia-reperfusion injury: processes in pathogenetic networks: a review. Transpl Proc 39:481-484 (Pubitemid 46386215)
4. Frangogiannis NG (2012) Regulation of the inflammatory response in cardiac repair. Circ Res 110:159-173
5. Nanni L, Romualdi C, Maseri A, Lanfranchi G (2006) Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. J Mol Cell Cardiol 41:934-948 (Pubitemid 44791333)
6. Huang XH, Pan W, Grindle S, Han XQ, Chen YJ, Park SJ et al (2005) A comparative study of discriminating human heart failure etiology using gene expression profiles. BMC Bioinform 6:205-218
7. Sanoudou D, Vafiadaki E, Arvanitis DA, Kranias E, Kontrogianni- Konstantopoulos A (2005) Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies. Physiol Genomics 21:131-143 (Pubitemid 40898473)
8. Gabrielsen A, Lawler PR, Wang YZ, Steinbruchel D, Blagoja D, Paulsson-Berne G et al (2007) Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. J Mol Cell Cardiol 42:870-883 (Pubitemid 46546392)
9. Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, Breton E et al (2005) Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics 21:299-307 (Pubitemid 40903130)
10. Prat-Vidal C, Galvez-Monton C, Nonell L, Puigdecanet E, Astier L, Sole F et al (2013) Identification of temporal and region-specific myocardial gene expression patterns in response to infarction in swine. PLoS ONE 8:e54785
11. Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148:1172-1187
12. Parker R, Song HW (2004) The enzymes and control of eukaryotic mRNA turnover. Nat Struct Mol Biol 11:121-127 (Pubitemid 38146514)
13. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102-114
14. Hwang HW, Wentzel EA, Mendell JT (2007) A hexanucleotide element directs microRNA nuclear import. Science 315:97-100 (Pubitemid 46196987)
15. Barrey E, Saint-Auret G, Bonnamy B, Damas D, Boyer O, Gidrol X (2011) Pre-microRNA and mature microRNA in human mitochondria. PLoS ONE 6:e20220
16. Kosaka N, Ochiya T (2011) Unraveling the mystery of cancer by secretory microRNA: horizontal microRNA transfer between living cells. Front Genet 2:97
17. Hosoda T, Zheng HQ, Cabral-da-Silva M, Sanada F, Ide-Iwata N, Ogorek B et al (2011) Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 123(12):1287-1296
18. Kim HW, Jiang SJ, Ashraf M, Haider KH (2012) Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function. J Mol Med (Berl) 90:997-1010
19. Liu JD, Valencia-Sanchez MA, Hannon GJ, Parker R (2005) MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7(7):719-723 (Pubitemid 40975754)
20. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140-D144
21. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
22. Friedman Y, Balaga O, Linial M (2013) Working together: combinatorial regulation by microRNAs. Adv Exp Med Biol 774:317-337
23. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J et al (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769-773 (Pubitemid 40292988)
24. Boettger T, Braun T (2012) A new level of complexity: the role of microRNAs in cardiovascular development. Circ Res 110:1000-1013
25. Divakaran V, Mann DL (2008) The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 103(10):1072-1083
26. Han M, Toli J, Abdellatif M (2011) MicroRNAs in the cardiovascular system. Curr Opin Cardiol 26:181-189
27. Kukreja RC, Yin C, Salloum FN (2011) MicroRNAs: new players in cardiac injury and protection. Mol Pharmacol 80:558-564
28. Ono K, Kuwabara Y, Han JH (2011) MicroRNAs and cardiovascular diseases. FEBS J 278:1619-1633
29. Zhao Y, Samal E, Srivastava D (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214-220 (Pubitemid 41021266)
30. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M et al (2007) Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42:1137-1141 (Pubitemid 46829201)
31. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD et al (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103:18255-18260 (Pubitemid 44871645)
32. van Rooij E, Sutherland LB, Qi XX, Richardson JA, Hill J, Olson EN (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:575-579 (Pubitemid 46683138)
33. Margulies KB, Matiwala S, Cornejo C, Olsen H, Craven WA, Bednarik D (2005) Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res 96:592-599 (Pubitemid 40463469)
34. Matkovich SJ, Van Booven DJ, Youker KA, Torre-Amione G, Diwan A, Eschenbacher WH et al (2009) Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 119:1263-1271
35. Liu N, Olson EN (2010) MicroRNA regulatory networks in cardiovascular development. Dev Cell 18:510-525
36. Small EM, Frost RJA, Olson EN (2010) MicroRNAs add a new dimension to cardiovascular disease. Circulation 121:1022-1032
37. van Rooij E, Liu N, Olson EN (2008) MicroRNAs flex their muscles. Trends Genet 24:159-166
38. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi XX, Richardson JA et al (2009) A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17:662-673
39. Chen JF, Mandel EM, Thomson JM, Wu QL, Callis TE, Hammond SM et al (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228-233 (Pubitemid 43177239)
40. Czubryt MP, McAnally J, Fishman GI, Olson EN (2003) Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci USA 100:1711-1716 (Pubitemid 36254513)
41. Liu N, Bezprozvannaya S, Williams AH, Qi XX, Richardson JA, Bassel-Duby R et al (2008) microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Gene Dev 22:3242-3254
42. McCarthy JJ, Esser KA (2007) MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. J Appl Phys 102:306-313 (Pubitemid 46089780)
43. Hua Z, Lv Q, Ye WB, Wong CKA, Cai GP, Gu DY et al (2006) miRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 1:e116
44. Migliore C, Martin V, Leoni VP, Restivo A, Atzori L, Petrelli A et al (2012) MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clin Cancer Res 18:737-747
45. Leo C, Sala V, Morello M, Chiribiri A, Riess I, Mancardi D et al (2011) Activated Met signalling in the developing mouse heart leads to cardiac disease. PLoS ONE 6:e14675
46. Sala V, Crepaldi T (2011) Novel therapy for myocardial infarction: can HGF/Met be beneficial? Cell Mol Life Sci 68:1703-1717
47. Elia L, Contu R, Quintavalle M, Varrone F, Chimenti C, Russo MA et al (2009) Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 120:2377-2385
48. Knezevic I, Patel A, Sundaresan NR, Gupta MP, Solaro RJ, Nagalingam RS et al (2012) A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor Implications in postnatal cardiac remodeling and cell survival. J Biol Chem 287:12913-12926
49. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion-from mechanism to translation. Nat Med 17:1391-1401
50. Oerlemans MIFJ, Koudstaal S, Chamuleau SA, de Kleijn DP, Doevendans PA, Sluijter JPG (2013) Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. Int J Cardiol 165:410-422
51. Xiao J, Zhu XY, He B, Zhang YF, Kang B, Wang ZN et al (2011) miR-204 regulates cardiomyocyte autophagy induced by ischemia-reperfusion through LC3-II. J Biomed Sci 18:35
52. Wang JX, Jiao JQ, Li QA, Long B, Wang K, Liu JP et al (2011) miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 17:71-78
53. Li JC, Donath S, Li YR, Qin D, Prabhakar BS, Li PF (2010) miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet 6:e1000795
54. Qian L, van Laake LW, Huang Y, Liu SY, Wendland MF, Srivastava D (2011) miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med 208:549-560
55. Dong SM, Cheng YH, Yang J, Li JY, Liu XJ, Wang XB et al (2009) MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284:29514-29525
56. Li DF, Tian J, Guo X, Huang LM, Xu Y, Wang CC et al (2012) Induction of microRNA-24 by HIF-1 protects against ischemic injury in rat cardiomyocytes. Physiol Res 61:555-565
57. 2-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 47:5-14
58. Cheng YH, Zhu P, Yang JA, Liu XJ, Dong SM, Wang XB et al (2010) Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 87:431-439
59. Hu SJ, Huang M, Nguyen PK, Gong YQ, Li ZJ, Jia FJ et al (2011) Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation 124:S27-S34
60. Meloni M, Marchetti M, Garner K, Littlejohns B, Sala-Newby G, Xenophontos N et al (2013) Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction. Mol Ther. doi:10.1038/mt.2013.89:
61. Chan YC, Banerjee J, Choi SY, Sen CK (2012) miR-210: the master hypoxamir. Microcirculation 19:215-223
62. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G et al (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283:15878-15883
63. Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H (2011) microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. Am J Physiol Heart Circ Physiol 301:H1519-H1530
64. Hu SJ, Huang M, Li ZJ, Jia FJ, Ghosh ZM, Lijkwan MA et al (2010) MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122:S124-S131
65. Kim HW, Haider HK, Jiang SJ, Ashraf M (2009) Ischemic preconditioning augments survival of stem cells via miR-210 Expression by targeting caspase-8-associated protein 2. J Biol Chem 284:33161-33168
66. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J (2009) MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 10:273-284
67. Chen Z, Li Y, Zhang H, Huang P, Luthra R (2010) Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 29:4362-4368
68. Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M et al (2010) MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS ONE 5:e10345
69. Ren XP, Wu JH, Wang XH, Sartor MA, Qian J, Jones K et al (2009) MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119:2357-2366
70. Hermeking H (2007) p53 enters the microRNA world. Cancer Cell 12:414-418
71. Bernardo BC, Gao XM, Winbanks CE, Boey EJH, Tham YK, Kiriazis H et al (2012) Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci USA 109:17615-17620
72. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S et al (2013) MicroRNA-34a regulates cardiac ageing and function. Nature 495:107-110
73. Ye YM, Hu ZY, Lin Y, Zhang CF, Perez-Polo JR (2010) Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury. Cardiovasc Res 87:535-544
74. Hullinger TG, Montgomery RL, Seto AG, Dickinson BA, Semus HM, Lynch JM et al (2012) Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res 110:71-81
75. Shan ZX, Lin QX, Fu YH, Deng CY, Zhou ZL, Zhu JN et al (2009) Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Bioph Res Co 381:597-601
76. Tang YH, Zheng JY, Sun Y, Wu ZG, Liu ZM, Huang GZ (2009) MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J 50:377-387
77. Xu CQ, Lu YJ, Pan ZW, Chu WF, Luo XB, Lin HX et al (2011) The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 124:3187 (retraction of vol 120, p 3045, 2007)
78. Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF et al (2012) Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 17:410-423
79. Wang XH, Zhang XW, Ren XP, Chen J, Liu HZ, Yang JQ et al (2010) MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 122:1308-1318
80. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M et al (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signaling in fibroblasts. Nature 456:980-984
81. Sayed D, Rane S, Lypowy J, He MZ, Chen IY, Vashistha H et al (2008) MicroRNA-21 targets sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19:3272-3282
82. Bronnum H, Andersen DC, Schneider M, Sandberg MB, Eskildsen T, Nielsen SB et al (2013) miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving programmed cell death 4 and sprouty-1. PLoS ONE 8(2):e56280
83. Roy S, Khanna S, Hussain SRA, Biswas S, Azad A, Rink C et al (2009) MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 82:21-29
84. Patrick DM, Montgomery RL, Qi XX, Obad S, Kauppinen S, Hill JA et al (2010) Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 120:3912-3916
85. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I et al (2009) miR-133 and miR-30 regulate connective tissue growth factor Implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104:170-178
86. van Rooij E, Sutherland LB, Thatcher JE, Dimaio JM, Naseem RH, Marshall WS et al (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105:13027-13032
87. Karakikes I (2013) Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc 2(2):e000078
88. Zhao N, Yu HY, Yu HT, Sun M, Zhang YY, Xu M et al (2013) miRNA-711-SP1-collagen-I pathway is involved in the antifibrotic effect of pioglitazone in myocardial infarction. Sci China-Ser C 56:431-439
89. Cushing L, Kuang PP, Qian J, Shao FZ, Wu JJ, Little F et al (2011) miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Resp Cell Mol Biol 45:287-294
90. Kwiecinski M, Noetel A, Elfimova N, Trebicka J, Schievenbusch S, Strack I et al (2011) Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS ONE 6:e24568
91. Liang HH, Zhang C, Ban T, Liu Y, Mei L, Piao XM et al (2012) A novel reciprocal loop between microRNA-21 and TGF beta RIII is involved in cardiac fibrosis. Int J Biochem Cell B 44:2152-2160
92. Wang J, Huang WC, Xu RX, Nie Y, Cao XQ, Meng J et al (2012) MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med 16:2150-2160
93. Pan ZW, Sun XL, Shan HL, Wang N, Wang JH, Ren JS et al (2012) MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-beta 1 pathway. Circulation 126:840-850
94. Yamakuchi M (2013) MicroRNAs in vascular biology. Int J Vasc Med. doi:10.1155/2012/794898
95. Wang SS, Aurora AB, Johnson BA, Qi XX, McAnally J, Hill JA et al (2008) The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15:261-271
96. van Mil A, Vrijsen KR, Goumans MJ, Metz CH, Doevendans PA, Sluijter JP (2013) MicroRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells. J Mol Med 91(8):1001-1012
97. Chen JJ, Zhou SH (2011) Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiol J 18:675-681
98. Huang F, Zhu X, Hu XQ, Fang ZF, Tang L, Lu XL et al (2013) Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. Int J Mol Med 31:484-492
99. Jakob P, Doerries C, Briand S, Mocharla P, Krankel N, Besler C et al (2012) Loss of AngiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure Role for impaired in vivo neovascularization and cardiac repair capacity. Circulation 126:2962-2975
100. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A et al (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324:1710-1713
101. Fiedler J, Jazbutyte V, Kirchmaier BC, Gupta SK, Lorenzen J, Hartmann D et al (2011) MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 124:720-730
102. van Mil A, Grundmann S, Goumans MJ, Lei ZY, Oerlemans MI, Jaksani S et al (2012) MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovasc Res 93:655-665
103. Ikeda S, Pu WT (2010) Expression and function of microRNAs in heart disease. Curr Drug Targets 11:913-925
104. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100:416-424
105. Sucharov C, Bristow MR, Port JD (2008) miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol 45:185-192
106. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW et al (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116:258-267 (Pubitemid 47196561)
107. Reddy S, Zhao MM, Hu DQ, Fajardo G, Hu SJ, Ghosh Z et al (2012) Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure. Physiol Genomics 44:562-575
108. 2+-ATPase in patients with advanced heart failure. Circulation 124:304-313
109. Kumarswamy R, Lyon AR, Volkmann I, Mills AM, Bretthauer J, Pahuja A et al (2012) SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur Heart J 33:1067-1075
110. Ikeda S, He AB, Kong SW, Lu J, Bejar R, Bodyak N et al (2009) MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol 29:2193-2204
111. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P et al (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613-618 (Pubitemid 46828487)
112. 2+ overload and cell death. J Clin Invest 122:1222-1232
113. (2+) overload of cardiomyocytes by targeting CaMKII? Biochem Biophys Res Commun 435:720-726
114. 2)-induced apoptosis through targeting the mitochondria apoptotic pathway. PLoS ONE 7:e44907
115. van Mil A, Grundmann S, Goumans MJ, Lei ZY, Oerlemans MI, Jaksani S et al (2012) MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovasc Res 93:655-665
116. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-10518
117. Tijsen AJ, Creemers E, Moerland PD, De Windt LJ, van der Wal AC, Kok WE et al (2010) MiR423-5p as a circulating biomarker for heart failure. Circ Res 106:1035-1039
118. Kumarswamy R, Thum T, Anker SD (2010) MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p. Circ Res 106:E8
119. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J et al (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31:659-666
120. Ai J, Zhang R, Li Y, Pu JL, Lu YJ, Jiao JD et al (2010) Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Communn 391:73-77
121. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L et al (2010) Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Gene 3:499-506
122. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M et al (2011) Increased MicroRNA-1 and MicroRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Gene 4:446-454
123. Long GW, Wang F, Duan QL, Yang SL, Chen FQ, Gong W et al (2012) Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS ONE 7:e24568
124. Oerlemans MIFJ, Mosterd A, Dekker MS, de Vrey EA, van Mil A, Pasterkamp G et al (2012) Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol Med 4:1176-1185
125. Abdellatif M (2012) Differential expression of microRNAs in different disease states. Circ Res 110:638-650
126. Cai BZ, Pan ZW, Lu YJ (2010) The roles of microRNAs in heart diseases: a novel important regulator. Curr Med Chem 17:407-411
127. Fasanaro P, Greco S, Ivan M, Capogrossi MC, Martelli F (2010) MicroRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Therap 125:92-104
128. Frost RJA, van Rooij E (2010) miRNAs as therapeutic targets in ischemic heart disease. J Cardiovasc Transl Res 3:280-289
129. Heyn J, Hinske C, Mohnle P, Luchting B, Beiras-Fernandez A, Kreth S (2011) MicroRNAs as potential therapeutic agents in the treatment of myocardial infarction. Curr Vasc Pharmacol 9:733-740
130. Montgomery RL, van Rooij E (2010) MicroRNA regulation as a therapeutic strategy for cardiovascular disease. Curr Drug Targets 11:936-942
131. van Rooij E, Purcell AL, Levin AA (2012) Developing microRNA therapeutics. Circ Res 110:496-507
132. Bish LT, Morine K, Sleeper MM, Sanmiguel J, Wu D, Gao GP et al (2008) Adeno-associated virus (aav) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther 19:1359-1368
133. Rane S, He MZ, Sayed D, Vashistha H, Malhotra A, Sadoshima J et al (2009) Downregulation of MiR-199a derepresses hypoxia-inducible factor-1 alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 104:879-886
134. Chan YC, Roy S, Huang Y, Khanna S, Sen CK (2012) The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway. J Biol Chem 287:41032-41043
135. Ahuja P, Sdek P, MaClellan WR (2007) Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 87:521-544 (Pubitemid 47086282)
136. Collesi C, Zentilin L, Sinagra G, Giacca M (2008) Notch1 signaling stimulates proliferation of immature cardiomyocytes. J Cell Biol 183:117-128
137. Li FQ, Wang XJ, Capasso JM, Gerdes AM (1996) Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28:1737-1746 (Pubitemid 26300573)
138. Soonpaa MH, Kim KK, Pajak L, Franklin M, Field LJ (1996) Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol-Heart C 271:H2183-H2189
139. Bicknell KA, Coxon CNH, Brooks G (2007) Can the cardiomyocyte cell cycle be reprogrammed? J Mol Cell Cardiol 42:706-721 (Pubitemid 46527595)
140. Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M et al (2013) Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493(7432):433-436
141. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R et al (2001) Evidence that human cardiac myocytes divide after myocardial infarction. New Engl J Med 344:1750-1757 (Pubitemid 32497029)
142. Kajstura J, Zhang X, Reiss K, Szoke E, Li P, Lagrasta C et al (1994) Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary-artery narrowing-induced cardiomyopathy in rats. Circ Res 74:383-400 (Pubitemid 24064188)
143. Reiss K, Kajstura J, Capasso JM, Marino TA, Anversa P (1993) Impairment of myocyte contractility following coronary-artery narrowing is associated with activation of the myocyte Igf(1) autocrine system, enhanced expression of late growth-related genes, dna-synthesis, and myocyte nuclear mitotic division in rats. Exp Cell Res 207:348-360 (Pubitemid 23246807)
144. Porrello ER, Johnson BA, Aurora AB, Simpson E, Nam YJ, Matkovich SJ et al (2011) miR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ Res 109:670-679
145. Porrello ER, Mahmoud AI, Simpson E, Johnson BA, Grinsfelder D, Canseco D et al (2013) Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci USA 110:187-192
146. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN et al (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:303-317 (Pubitemid 46574975)
147. Yin VP, Lepilina A, Smith A, Poss KD (2012) Regulation of zebrafish heart regeneration by miR-133. Dev Biol 365:319-327
148. Jopling C, Sleep E, Raya M, Marti M, Raya A, Belmonte JCI (2010) Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 464(7288):606-609
149. (+) cardiomyocytes. Nature 464:601-605
150. Poss KD, Nechiporuk A, Hillam AM, Johnson SL, Keating MT (2002) Mps1 defines a proximal blastemal proliferative compartment essential for zebrafish fin regeneration. Development 129:5141-5149 (Pubitemid 35460678)
151. Chen J, Huang ZP, Seok HY, Ding J, Kataoka M, Zhang Z et al (2013) Mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ Res 112:1557-1566
152. Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S et al (2012) Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492:376-381
153. Porrello ER (2013) microRNAs in cardiac development and regeneration. Clin Sci (Lond) 125:151-166
154. Srivastava D (2013) Small solutions to big problems: micrornas for cardiac regeneration. Circ Res 112:1412-1414
155. van Amerongen MJ, Engel FB (2008) Features of cardiomyocyte proliferation and its potential for cardiac regeneration. J Cell Mol Med 12:2233-2244
156. Anversa P, Nadal-Ginard B (2002) Myocyte renewal and ventricular remodelling. Nature 415:240-243 (Pubitemid 34059531)
157. van Vliet P, Roccio M, Smits AM, van Oorschot AAM, Metz CHG, van Veen TAB et al (2008) Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J 16:163-169
158. Segers VFM, Lee RT (2008) Stem-cell therapy for cardiac disease. Nature 451:937-942 (Pubitemid 351301749)
159. Kuppusamy KT (2013) MicroRNA regulation and role in stem cell maintenance, cardiac differentiation and hypertrophy. Curr Mol Med 13:757-764
160. Scott E (2013) miRNA regulation of endothelial homeostasis and commitment: implications for vascular regeneration strategies using stem cell therapies. Free Radic Biol Med (in press)
161. Brás-Rosário L, Matsuda A, Pinheiro AI, Gardner R, Lopes T, Amaral A, Gama-Carvalho M (2013) Expression profile of microRNAs regulating proliferation and differentiation in mouse adult cardiac stem cells. PLoS ONE 8(5):e63041
162. Sirish P, Lopez JE, Li N, Wong A, Timofeyev V, Young JN et al (2012) MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts. J Mol Cell Cardiol 52:264-272
163. Xiao JJ, Liang DD, Zhang H, Liu Y, Zhang DS, Liu Y et al (2012) MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells. J Mol Cell Cardiol 53:751-759
164. Heinrich EM, Dimmeler S (2012) MicroRNAs and stem cells control of pluripotency, reprogramming, and lineage commitment. Circ Res 110:1014-1022